Background Although clozapine is effective for treatment-resistant schizophrenia (TRS), the
rate of clozapine prescription is still low. Whereas antipsychotic monotherapy is …

Aim This study aims to examine the real‐world effectiveness of education regarding clinical
guidelines for psychiatric disorders using 'the Effectiveness of guidelines for dissemination …

Study objectives To investigate the proportion of inpatients with schizophrenia and major
depressive disorder prescribed hypnotic medication, and the association between such …

Background Clinician adherence to guideline recommendations in the pharmacological
therapy of schizophrenia is important for favorable patient outcomes. To evaluate whether …

Background The decision to initiate clozapine treatment should be made on an individual
basis and may be closely related to the early detection of treatment‐resistant schizophrenia …

Background Clinical practice guidelines for schizophrenia and major depressive disorder
have been published. However, these have not had sufficient penetration in clinical settings …

Background Although several guidelines indicate that daily pharmacotherapy is an
important part of the treatment of schizophrenia and major depressive disorder, there are …

Purpose In the treatment guidelines for major depressive disorder (MDD), the recommended
treatment differs based on the severity. However, the type of treatment provided based on …

In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not
recommended. We investigated the characteristics of the use of anticholinergics in patients …

Abstract The Effectiveness of Guidelines for Dissemination and Education in psychiatric
treatment (EGUIDE) project, which is a nationwide dissemination and implementation …